Insiders · OVID

OVID insider transactions

Ovid Therapeutics Inc. (OVID) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for OVID

• 60d
  SEC Form 4 filed by Papadopoulos Stelios

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 60d
  SEC Form 4 filed by Fitzgerald Kevin Joseph

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 60d
  SEC Form 4 filed by Friedman Bart

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 75d
  SEC Form 4 filed by Levin Jeremy M

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  President and CEO Alexander Margaret A. sold $16,901 worth of shares (11,656 units at $1.45), decreasing direct ownership by 16% to 61,750 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  SEC Form 4 filed by Director Papadopoulos Stelios

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  SEC Form 4 filed by Director Fitzgerald Kevin Joseph

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  SEC Form 4 filed by Director Levin Jeremy M

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  SEC Form 4 filed by Director Friedman Bart

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  SEC Form 4 filed by Director Duncan Barbara Gayle

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  CBFO Rona Jeffrey A sold $12,384 worth of shares (8,541 units at $1.45) and was granted 68,125 shares, increasing direct ownership by 62% to 156,313 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 98d
  SEC Form 4 filed by Director Bernstein Karen

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 154d
  SEC Form 4 filed by President and CEO Alexander Margaret A.

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 172d
  CEO Levin Jeremy M converted options into 71,000 shares, increasing direct ownership by 2% to 3,687,715 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 355d
  SEC Form 4 filed by Director Friedman Bart

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 355d
  SEC Form 4 filed by Director Fitzgerald Kevin Joseph

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 355d
  SEC Form 4 filed by Director Duncan Barbara Gayle

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 355d
  SEC Form 4 filed by Director Bernstein Karen

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 461d
  SEC Form 4 filed by Director Papadopoulos Stelios

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 461d
  New insider Papadopoulos Stelios claimed ownership of 200,000 shares (SEC Form 3)

  3 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 465d
  CBFO Rona Jeffrey A sold $2,185 worth of shares (3,902 units at $0.56), decreasing direct ownership by 5% to 67,973 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 465d
  President and COO Alexander Margaret A. sold $2,956 worth of shares (5,279 units at $0.56), decreasing direct ownership by 7% to 73,406 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 469d
  SEC Form 4 filed by CEO Levin Jeremy M

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 469d
  President and COO Alexander Margaret A. was granted 43,750 shares, increasing direct ownership by 125% to 78,685 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 469d
  CBFO Rona Jeffrey A was granted 43,750 shares, increasing direct ownership by 156% to 71,875 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 495d
  President and COO Alexander Margaret A. bought $4,971 worth of shares (6,810 units at $0.73), increasing direct ownership by 24% to 34,935 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 539d
  SEC Form 4 filed by Director Friedman Bart

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 539d
  SEC Form 4 filed by Director Fitzgerald Kevin Joseph

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 539d
  SEC Form 4 filed by Director Bernstein Karen

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 539d
  SEC Form 4 filed by Director Duncan Barbara Gayle

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 635d
  SEC Form 4 filed by President and COO Alexander Margaret A.

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 635d
  New insider Alexander Margaret A. claimed ownership of 28,125 shares (SEC Form 3)

  3 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 676d
  SEC Form 4 filed by CBFO Rona Jeffrey A

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 810d
  Levin Jeremy M bought $50,364 worth of shares (18,248 units at $2.76), increasing direct ownership by 0.51% to 3,616,715 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  Tardio Jason was granted 28,125 shares (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  Rona Jeffrey A was granted 28,125 shares (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  SEC Form 4 filed by Poole Robert Michael

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  Perone Thomas Michael was granted 28,125 shares (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  SEC Form 4 filed by Levin Jeremy M

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  SEC Form 4 filed by Friedman Bart

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  SEC Form 4 filed by Fitzgerald Kevin Joseph

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 833d
  SEC Form 4 filed by Bernstein Karen

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 845d
  Levin Jeremy M gifted 465,116 shares (SEC Form 4) (Amendment)

  4/A - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 915d
  Levin Jeremy M gifted 1,146,550 shares, decreasing direct ownership by 24% to 3,598,467 units (SEC Form 4)

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1197d
  SEC Form 4 filed by Tardio Jason

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1197d
  SEC Form 4 filed by Rona Jeffrey A

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1197d
  SEC Form 4 filed by Poole Robert Michael

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1197d
  SEC Form 4 filed by Fitzgerald Kevin Joseph

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1197d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1197d
  SEC Form 4 filed by Bernstein Karen

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1363d
  SEC Form 4: Tardio Jason sold $37,290 worth of shares (17,344 units at $2.15), closing all direct ownership in the company

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1433d
  SEC Form 4: Takeda Pharmaceutical Co Ltd disposed of 5,750,000 shares and acquired 5,750,000 shares

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Friedman Bart

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Tardio Jason

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Levin Jeremy M

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Rona Jeffrey A

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Perone Thomas Michael

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)
• 1518d
  SEC Form 4 filed by Bernstein Karen

  4 - Ovid Therapeutics Inc. (0001636651) (Issuer)